Bruce W. Surber

Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a <i>Bona Fide</i> PARP Inhibitor

Xuesong Liu, Yan Shi, David Maag et al. · Clinical Cancer Research · 2011 · 175 citations · Full text

Medicine, Oncology, Pharmacology +11

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi Kumar, J.C. Dykstra, Ellen Roberts et al. · Drug Metabolism and Disposition · 1999 · 166 citations

Medicine, Pharmacokinetics, Pharmacology +17

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +14

Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Jon F. Denissen, Brian Grabowski, Marianne K. Johnson et al. · PubMed · 1997 · 131 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Acetylenic esters. Preparation and mechanism of formation of alkynyl tosylates and mesylates via tricoordinate iodonium species

Peter J. Stang, Bruce W. Surber, Zhen Chu Chen et al. · Journal of the American Chemical Society · 1987 · 118 citations

Natural Sciences, Chemistry, Analytical Chemistry +6